Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(2):183–191. doi: 10.1155/S1064744997000288

Recurrent Fetal Loss and Antiphospholipid Antibodies: Clinical and Therapeutic Aspects

O Blétry 1,✉, A-M Piette 1
PMCID: PMC2364563  PMID: 18476173

Abstract

Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the third consecutive fetal loss, or when they occur after 12 weeks gestation or when the mother presents with thrombosis or other ailments of antiphospholipid syndrome. Fetal loss may be caused by thromboses of placental vasculature. There is no agreement concerning the mechanism of thromboses: protein C pathway and/or annexin V are the best candidates. When fetal loss occurs early during gestation, murine models suggest that antiphospholipid antibodies can also act on trophoblasts by inhibiting syncytia formation. Among the high risk patients with more than two fetal losses, an association of aspirin and heparin given early during gestation is successful in 70–80% of cases.

Full Text

The Full Text of this article is available as a PDF (788.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Delezé M., Oria C. V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., Fernández L., Ponce de León S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989 Nov;68(6):353–365. doi: 10.1097/00005792-198911000-00003. [DOI] [PubMed] [Google Scholar]
  2. Aoki K., Dudkiewicz A. B., Matsuura E., Novotny M., Kaberlein G., Gleicher N. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol. 1995 Mar;172(3):926–931. doi: 10.1016/0002-9378(95)90023-3. [DOI] [PubMed] [Google Scholar]
  3. Bokarewa M. I., Bremme K., Falk G., Sten-Linder M., Egberg N., Blombäck M. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. Thromb Res. 1995 May 1;78(3):193–200. doi: 10.1016/0049-3848(95)00048-v. [DOI] [PubMed] [Google Scholar]
  4. Branch D. W., Andres R., Digre K. B., Rote N. S., Scott J. R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989 Apr;73(4):541–545. [PubMed] [Google Scholar]
  5. Branch D. W., Dudley D. J., Mitchell M. D., Creighton K. A., Abbott T. M., Hammond E. H., Daynes R. A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 1):210–216. doi: 10.1016/s0002-9378(11)90700-5. [DOI] [PubMed] [Google Scholar]
  6. Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 Nov 21;313(21):1322–1326. doi: 10.1056/NEJM198511213132104. [DOI] [PubMed] [Google Scholar]
  7. Branch D. W., Silver R. M., Blackwell J. L., Reading J. C., Scott J. R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992 Oct;80(4):614–620. [PubMed] [Google Scholar]
  8. Branch D. W. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus. 1994 Aug;3(4):275–280. doi: 10.1177/096120339400300414. [DOI] [PubMed] [Google Scholar]
  9. Brenner B., Mandel H., Lanir N., Younis J., Rothbart H., Ohel G., Blumenfeld Z. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol. 1997 Jun;97(3):551–554. doi: 10.1046/j.1365-2141.1997.882901.x. [DOI] [PubMed] [Google Scholar]
  10. Carreras L. D., Perez G. N., Vega H. R., Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet. 1988 Aug 13;2(8607):393–394. doi: 10.1016/s0140-6736(88)92859-0. [DOI] [PubMed] [Google Scholar]
  11. Carreras L. O., Vermylen J. G. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation. Thromb Haemost. 1982 Aug 24;48(1):38–40. [PubMed] [Google Scholar]
  12. Cervera R., Asherson R. A., Font J., Tikly M., Pallarés L., Chamorro A., Ingelmo M. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997 May;76(3):203–212. doi: 10.1097/00005792-199705000-00006. [DOI] [PubMed] [Google Scholar]
  13. Coulam C. B. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol. 1991 Aug;26(1):23–27. doi: 10.1111/j.1600-0897.1991.tb00697.x. [DOI] [PubMed] [Google Scholar]
  14. Cowchock F. S., Reece E. A., Balaban D., Branch D. W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992 May;166(5):1318–1323. doi: 10.1016/0002-9378(92)91596-3. [DOI] [PubMed] [Google Scholar]
  15. Creagh M. D., Malia R. G., Cooper S. M., Smith A. R., Duncan S. L., Greaves M. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. J Clin Pathol. 1991 Jan;44(1):45–47. doi: 10.1136/jcp.44.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Crowther M. A., Johnston M., Weitz J., Ginsberg J. S. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus. Thromb Haemost. 1996 Nov;76(5):689–691. [PubMed] [Google Scholar]
  17. Dahlman T., Lindvall N., Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol. 1990 Mar;97(3):221–228. doi: 10.1111/j.1471-0528.1990.tb01785.x. [DOI] [PubMed] [Google Scholar]
  18. De Wolf F., Carreras L. O., Moerman P., Vermylen J., Van Assche A., Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 1982 Apr 1;142(7):829–834. doi: 10.1016/s0002-9378(16)32527-3. [DOI] [PubMed] [Google Scholar]
  19. Deleze M., Alarcón-Segovia D., Valdes-Macho E., Oria C. V., Ponce de Leon S. Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol. 1989 Jun;16(6):768–772. [PubMed] [Google Scholar]
  20. Derksen R. H., Bouma B. N., Kater L. The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients. Arthritis Rheum. 1986 May;29(5):695–696. doi: 10.1002/art.1780290520. [DOI] [PubMed] [Google Scholar]
  21. Douketis J. D., Ginsberg J. S., Burrows R. F., Duku E. K., Webber C. E., Brill-Edwards P. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost. 1996 Feb;75(2):254–257. [PubMed] [Google Scholar]
  22. Edelman P., Verdy E., Rouquette A. M., Cornet D., Combrisson A., Barrat J., Chavinie J., Salat Baroux J., Sureau C. Désordres immunologiques de la coagulation dans la maladie abortive. Etude prospective. Presse Med. 1986 May 24;15(21):961–964. [PubMed] [Google Scholar]
  23. Ehrenforth S., Radtke K. P., Scharrer I. Acquired activated protein C-resistance in patients with lupus anticoagulants. Thromb Haemost. 1995 Aug;74(2):797–798. [PubMed] [Google Scholar]
  24. Frampton G., Cameron J. S., Thom M., Jones S., Raftery M. Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone. Lancet. 1987 Oct 31;2(8566):1023–1024. doi: 10.1016/s0140-6736(87)92584-0. [DOI] [PubMed] [Google Scholar]
  25. Francois A., Freund M., Daffos F., Remy P., Aiach M., Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Intern Med. 1988 Dec 15;109(12):993–994. doi: 10.7326/0003-4819-109-12-993. [DOI] [PubMed] [Google Scholar]
  26. Fulcher D., Stewart G., Exner T., Trudinger B., Jeremy R. Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet. 1989 Jul 15;2(8655):171–171. doi: 10.1016/s0140-6736(89)90242-0. [DOI] [PubMed] [Google Scholar]
  27. Ginsberg J. S., Brill-Edwards P., Johnston M., Denburg J. A., Andrew M., Burrows R. F., Bensen W., Cividino A., Long A. A. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood. 1992 Aug 15;80(4):975–980. [PubMed] [Google Scholar]
  28. Ginsberg J. S., Demers C., Brill-Edwards P., Bona R., Johnston M., Wong A., Denburg J. A. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med. 1995 Apr;98(4):379–383. doi: 10.1016/S0002-9343(99)80317-9. [DOI] [PubMed] [Google Scholar]
  29. Gleicher N., Pratt D., Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity. 1993;16(2):115–140. doi: 10.3109/08916939308993318. [DOI] [PubMed] [Google Scholar]
  30. Godeau P., Blétry O., Piette J. C., Wechsler B. Anticoagulants circulants. Les conditions cliniques du diagnostic. Rev Med Interne. 1985 Dec;6(5):523–541. doi: 10.1016/s0248-8663(85)80035-7. [DOI] [PubMed] [Google Scholar]
  31. Hanly J. G., Gladman D. D., Rose T. H., Laskin C. A., Urowitz M. B. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum. 1988 Mar;31(3):358–366. doi: 10.1002/art.1780310307. [DOI] [PubMed] [Google Scholar]
  32. Harris E. N., Chan J. K., Asherson R. A., Aber V. R., Gharavi A. E., Hughes G. R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med. 1986 Nov;146(11):2153–2156. [PubMed] [Google Scholar]
  33. Howard M. A., Firkin B. G., Healy D. L., Choong S. C. Lupus anticoagulant in women with multiple spontaneous miscarriage. Am J Hematol. 1987 Oct;26(2):175–178. doi: 10.1002/ajh.2830260208. [DOI] [PubMed] [Google Scholar]
  34. Inbar O., Blank M., Faden D., Tincani A., Lorber M., Shoenfeld Y. Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 1):423–426. doi: 10.1016/0002-9378(93)90100-w. [DOI] [PubMed] [Google Scholar]
  35. Infante-Rivard C., David M., Gauthier R., Rivard G. E. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med. 1991 Oct 10;325(15):1063–1066. doi: 10.1056/NEJM199110103251503. [DOI] [PubMed] [Google Scholar]
  36. Khamashta M. A., Mackworth-Young C. Antiphospholipid (Hughes') syndrome. BMJ. 1997 Jan 25;314(7076):244–244. doi: 10.1136/bmj.314.7076.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kupferminc M. J., Lee M. J., Green D., Peaceman A. M. Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies. Obstet Gynecol. 1994 May;83(5 Pt 2):806–807. [PubMed] [Google Scholar]
  38. Kutteh W. H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996 May;174(5):1584–1589. doi: 10.1016/s0002-9378(96)70610-5. [DOI] [PubMed] [Google Scholar]
  39. Laskin C. A., Bombardier C., Hannah M. E., Mandel F. P., Ritchie J. W., Farewell V., Farine D., Spitzer K., Fielding L., Soloninka C. A. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 1997 Jul 17;337(3):148–153. doi: 10.1056/NEJM199707173370302. [DOI] [PubMed] [Google Scholar]
  40. Lockshin M. D., Druzin M. L., Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 1989 Feb;160(2):439–443. doi: 10.1016/0002-9378(89)90468-7. [DOI] [PubMed] [Google Scholar]
  41. Lockshin M. D., Qamar T., Druzin M. L., Goei S. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol. 1987 Apr;14(2):259–262. [PubMed] [Google Scholar]
  42. Lockwood C. J., Romero R., Feinberg R. F., Clyne L. P., Coster B., Hobbins J. C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol. 1989 Aug;161(2):369–373. doi: 10.1016/0002-9378(89)90522-x. [DOI] [PubMed] [Google Scholar]
  43. Loizou S., Byron M. A., Englert H. J., David J., Hughes G. R., Walport M. J. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med. 1988 Jul;68(255):525–531. [PubMed] [Google Scholar]
  44. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  45. Lubbe W. F., Liggins G. C. Lupus anticoagulant and pregnancy. Am J Obstet Gynecol. 1985 Oct 1;153(3):322–327. doi: 10.1016/s0002-9378(85)80124-1. [DOI] [PubMed] [Google Scholar]
  46. Lyden T. W., Vogt E., Ng A. K., Johnson P. M., Rote N. S. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol. 1992 Jun;22(1):1–14. doi: 10.1016/0165-0378(92)90002-l. [DOI] [PubMed] [Google Scholar]
  47. Lynch A., Marlar R., Murphy J., Davila G., Santos M., Rutledge J., Emlen W. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med. 1994 Mar 15;120(6):470–475. doi: 10.7326/0003-4819-120-6-199403150-00004. [DOI] [PubMed] [Google Scholar]
  48. Lê Thi Huong D., Wechsler B., Edelman P., Fournié A., Le Tallec Y., Piette J. C., Godeau P. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome. J Rheumatol. 1993 Jul;20(7):1229–1232. [PubMed] [Google Scholar]
  49. Martorell J. R., Muñoz-Castillo A., Gil J. L. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract. Thromb Haemost. 1995 Aug;74(2):796–797. [PubMed] [Google Scholar]
  50. Mueller-Eckhardt G., Heine O., Polten B. IVIG to prevent recurrent spontaneous abortion. Lancet. 1991 Feb 16;337(8738):424–425. doi: 10.1016/0140-6736(91)91197-3. [DOI] [PubMed] [Google Scholar]
  51. Nilsson I. M., Astedt B., Hedner U., Berezin D. Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand. 1975 Mar;197(3):153–159. doi: 10.1111/j.0954-6820.1975.tb04897.x. [DOI] [PubMed] [Google Scholar]
  52. Out H. J., Kooijman C. D., Bruinse H. W., Derksen R. H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol. 1991 Oct 8;41(3):179–186. doi: 10.1016/0028-2243(91)90021-c. [DOI] [PubMed] [Google Scholar]
  53. Parke A. L., Wilson D., Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum. 1991 Oct;34(10):1231–1235. doi: 10.1002/art.1780341005. [DOI] [PubMed] [Google Scholar]
  54. Parke A., Maier D., Wilson D., Andreoli J., Ballow M. Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy. Ann Intern Med. 1989 Mar 15;110(6):495–496. doi: 10.7326/0003-4819-110-6-495_2. [DOI] [PubMed] [Google Scholar]
  55. Petri M., Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol. 1993 Apr;20(4):650–656. [PubMed] [Google Scholar]
  56. Petri M., Golbus M., Anderson R., Whiting-O'Keefe Q., Corash L., Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum. 1987 Jun;30(6):601–606. doi: 10.1002/art.1780300601. [DOI] [PubMed] [Google Scholar]
  57. Petri M., Howard D., Repke J., Goldman D. W. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):188–191. doi: 10.1111/j.1600-0897.1992.tb00788.x. [DOI] [PubMed] [Google Scholar]
  58. Piette J. C., Wechsler B., Blétry O., Godeau P. Quels critères pour le diagnostic du syndrome des antiphospholipides? Rev Med Interne. 1993;14(8):799–803. doi: 10.1016/s0248-8663(05)81428-6. [DOI] [PubMed] [Google Scholar]
  59. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ. 1997 Jan 25;314(7076):253–257. doi: 10.1136/bmj.314.7076.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Rand J. H., Wu X. X., Andree H. A., Lockwood C. J., Guller S., Scher J., Harpel P. C. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. N Engl J Med. 1997 Jul 17;337(3):154–160. doi: 10.1056/NEJM199707173370303. [DOI] [PubMed] [Google Scholar]
  61. Reber G., Arvieux J., Comby E., Degenne D., de Moerloose P., Sanmarco M., Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose). Thromb Haemost. 1995 Mar;73(3):444–452. [PubMed] [Google Scholar]
  62. Rosove M. H., Tabsh K., Wasserstrum N., Howard P., Hahn B. H., Kalunian K. C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol. 1990 Apr;75(4):630–634. [PubMed] [Google Scholar]
  63. Rossi E., Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL): a pilot study. Lupus. 1993 Oct;2(5):319–323. doi: 10.1177/096120339300200508. [DOI] [PubMed] [Google Scholar]
  64. Rote N. S., Dostal-Johnson D., Branch D. W. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol. 1990 Aug;163(2):575–584. doi: 10.1016/0002-9378(90)91201-m. [DOI] [PubMed] [Google Scholar]
  65. Scott J. R., Branch D. W., Kochenour N. K., Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol. 1988 Nov;159(5):1055–1056. doi: 10.1016/0002-9378(88)90411-5. [DOI] [PubMed] [Google Scholar]
  66. Sher G., Feinman M., Zouves C., Kuttner G., Maassarani G., Salem R., Matzner W., Ching W., Chong P. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod. 1994 Dec;9(12):2278–2283. doi: 10.1093/oxfordjournals.humrep.a138437. [DOI] [PubMed] [Google Scholar]
  67. Sibai B. M., Caritis S. N., Thom E., Klebanoff M., McNellis D., Rocco L., Paul R. H., Romero R., Witter F., Rosen M. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993 Oct 21;329(17):1213–1218. doi: 10.1056/NEJM199310213291701. [DOI] [PubMed] [Google Scholar]
  68. Silveira L. H., Hubble C. L., Jara L. J., Saway S., Martínez-Osuna P., Seleznick M. J., Angel J., O'Brien W., Espinoza L. R. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med. 1992 Oct;93(4):403–411. doi: 10.1016/0002-9343(92)90170-g. [DOI] [PubMed] [Google Scholar]
  69. Silver R. K., MacGregor S. N., Sholl J. S., Hobart J. M., Neerhof M. G., Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol. 1993 Dec;169(6):1411–1417. doi: 10.1016/0002-9378(93)90410-k. [DOI] [PubMed] [Google Scholar]
  70. Spinnato J. A., Clark A. L., Pierangeli S. S., Harris E. N. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):690–694. doi: 10.1016/0002-9378(95)90595-2. [DOI] [PubMed] [Google Scholar]
  71. Sthoeger Z. M., Mozes E., Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6464–6467. doi: 10.1073/pnas.90.14.6464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Sánchez-Guerrero J., Alarcón-Segovia D. Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol. 1992 Jul;19(7):1083–1088. [PubMed] [Google Scholar]
  73. Thornton J. G., Foote G. A., Page C. E., Clayden A. D., Tovey L. A., Scott J. S. False positive results of tests for syphilis and outcome of pregnancy: a retrospective case-control study. Br Med J (Clin Res Ed) 1987 Aug 8;295(6594):355–356. doi: 10.1136/bmj.295.6594.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Thorp J. M., Jr, Chescheir N. C., Fann B. Postpartum myocardial infarction in a patient with antiphospholipid syndrome. Am J Perinatol. 1994 Jan;11(1):1–3. doi: 10.1055/s-2007-994522. [DOI] [PubMed] [Google Scholar]
  75. Unander A. M., Norberg R., Hahn L., Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol. 1987 Jan;156(1):114–119. doi: 10.1016/0002-9378(87)90218-3. [DOI] [PubMed] [Google Scholar]
  76. Uzan S., Beaufils M., Breart G., Bazin B., Capitant C., Paris J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet. 1991 Jun 15;337(8755):1427–1431. doi: 10.1016/0140-6736(91)93124-r. [DOI] [PubMed] [Google Scholar]
  77. Wapner R. J., Cowchock F. S., Shapiro S. S. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol. 1989 Nov;161(5):1271–1272. doi: 10.1016/0002-9378(89)90681-9. [DOI] [PubMed] [Google Scholar]
  78. Wise P. H., Hall A. J. Heparin-induced osteopenia in pregnancy. Br Med J. 1980 Jul 12;281(6233):110–111. doi: 10.1136/bmj.281.6233.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. de Groot P. G., Derksen R. H. Protein C pathway, antiphospholipid antibodies and thrombosis. Lupus. 1994 Aug;3(4):229–233. doi: 10.1177/096120339400300405. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES